Cardinal Capital Management

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1434845 RALEIGH, NC

Position in HALO

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$2,197,508

+$869,427 QoQ

Shares Held

28,076

+36.6% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#232

of 664 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cardinal Capital Management holds $11,015,873 across 3 Biotechnology names. HALO ranks #3 (19.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	8,397	$5,235,865
2	JAZZ	Jazz Pharmaceuticals plc	14,867	$3,582,500
3	HALO	Halozyme Therapeutics, Inc. This page	28,076	$2,197,508

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,197,508	28,076	+36.6%	Shares	Sole	2026-07-21
2026-03-31	$1,328,081	20,549	+10.0%	Shares	Sole	2026-04-08
2025-12-31	$1,257,769	18,689	+5.2%	Shares	Sole	2026-01-30
2025-09-30	$1,303,105	17,768	—	Shares	Sole	2025-10-23
No filing history on record for this holder in this stock.